New stroke-prevention drug may not be cost effective for all patients

A new study has shown a stroke-prevention drug designed to be an improvement over prior treatments is less cost-effective for most patients than warfarin, the blood thinner with a 50-year history of helping prevent blood clots and strokes. The study, conducted by researchers at the School of Medicine found, however, that the new drug would be cost-effective for those atrial fibrillation patients whose risk of bleeding is high.

February 2005 Radio Service

Listed below are this month’s featured news stories. • Is field turf safe? (week of Feb. 2) • Heart surgery and depression (week of Feb. 9) • Reversing Alzheimer’s in mice (week of Feb. 16) • Age affects cervical cancer treatments (week of Feb. 23)

Biotech boost

Photo by Robert BostonUniversity and city officials celebrate the groundbreaking of the nonprofit Center of Research, Technology & Entrepreneurial Exchange.

Treating the whole patient

Sometimes, the innocence of youth is captured in a moment; other times, in a place. For Abby S. Hollander, M.D., associate professor of pediatrics, that place was — and is — summer camp. While growing up, Hollander spent many summers as a camper and counselor at Camp New Moon, tucked among pine trees in the […]
View More Stories